Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
5 Things Not to Say to Someone With Crohns GLP-1s May Decrease Crohns Complications GLP-1s May Work Especially Well for Crohns With Diabetes Not All Research Shows Positive Effects for IBD It is unclear whether all patients with Crohn's would benefit from these drugs or just patients with existing metabolic complications like diabetes or obesity, says Cohen
Therefore both B12 and folate deficiency can result in anaemia and intestinal atrophy
Legitimate Research Directions: Some peptides DO have potential and are being properly studied: Thymosin Alpha-1: Immune support (approved in 35+ countries, trials in US) BPC-157: IF proper human trials ever happen LL-37: Antimicrobial applications Others: Many peptides have theoretical promise But ONLY if studied properly: Randomized controlled trials Safety studies FDA approval process Medical supervision The Problem: Most "wellness peptides" will NEVER go through this process because: They can't be patented (no profit incentive) Companies would rather sell in gray market Proper trials cost $100M+ If trials show they DON'T work, the market disappears So we're stuck in limbo: promising animal data, zero human data, aggressive marketing
That relationship does not change the conclusion below
